Literature DB >> 16295819

Acute respiratory distress syndrome in a child with Kawasaki disease.

April Lynne Palmer1, Thomas Walker, J Clinton Smith.   

Abstract

This report presents a case of classic Kawasaki disease with progression to acute respiratory distress syndrome. The severity of the patient's pulmonary disease led clinicians to suspect toxic shock syndrome. Clinicians need to be aware that pulmonary manifestations of Kawasaki disease can include acute respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16295819     DOI: 10.1097/01.smj.0000182176.71475.a9

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  Marked coronary artery dilation in a young adult requiring extracorporeal membrane oxygenation support for adult respiratory distress syndrome due to Kawasaki disease.

Authors:  Abdul Rasheed; Ranjith Leanage; Richard K Firmin
Journal:  BMJ Case Rep       Date:  2009-06-11

2.  Shock: an unusual presentation of Kawasaki disease.

Authors:  Farah Thabet; Hend Bafaqih; Suleiman Al-Mohaimeed; Mariam Al-Hilali; Wafaa Al-Sewairi; May Chehab
Journal:  Eur J Pediatr       Date:  2011-02-24       Impact factor: 3.183

Review 3.  Kawasaki disease shock syndrome with acute respiratory distress syndrome in a child: a case report and literature review.

Authors:  Jingwei Liu; Chunfeng Yang; Zhen Zhang; Yumei Li
Journal:  BMC Pulm Med       Date:  2022-06-06       Impact factor: 3.320

4.  Recognition of a Kawasaki disease shock syndrome.

Authors:  John T Kanegaye; Matthew S Wilder; Delaram Molkara; Jeffrey R Frazer; Joan Pancheri; Adriana H Tremoulet; Virginia E Watson; Brookie M Best; Jane C Burns
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

5.  Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production.

Authors:  John W Semple; Michael Kim; Jing Hou; Mark McVey; Young Jin Lee; Arata Tabuchi; Wolfgang M Kuebler; Zhong-Wei Chai; Alan H Lazarus
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.